Table 2 Characteristics of patient groups with and without CNVs
From: De novo and rare inherited copy-number variations in the hemiplegic form of cerebral palsy
CNVa | Non-CNVa | Test statistic | Significance | |
---|---|---|---|---|
Participant characteristics | ||||
Age (years) χ (s) | 8.35 (4.84) | 9.67 (4.90) | −1.1b | 0.26 |
Sex | ||||
Male | 8 (34.8%) | 51 (68.9%) | 8.6b | 0.006 |
Female | 15 (65.2%) | 23 (31.1%) | ||
Hemiplegia n (%) | ||||
Left | 13 (56.5%) | 37 (51.4%) | ||
Right | 10 (43.5%) | 35 (48.6%), M=2 | 1.1b | 0.58 |
Neuroimaging n (%) | ||||
MCA | 7 (30.4%) | 24 (32.4%) | ||
PVI | 10 (43.5%) | 30 (40.5%) | 2.9b | 0.24 |
Otherc | 1 (4.34%) | 4 (5.4%) | ||
Not available | 5 (21.7%) | 16 (21.6%) | ||
Quality of Upper Extremity Skills Test score χ(s) | 63.24 (27.1) | 63.79 (30.5) | −0.1d | 0.94 |
Full Scale IQ percentile scoree χ(s) | 35.47 (26.9) | 46.08 (31.1) | −1.2d | 0.28 |
Potential risk factors for CP | ||||
Advanced maternal age (≥35 years) n (%) | 9 (39.1%) | 18 (25.7%), M=4 | 1.5b | 0.29 |
Family history of genetic risk factorsf n (%) | 4 (17.4%) | 15 (20.8%), M=2 | 0.8b | 0.68 |
Use of in vitro fertilization n (%) | 1 (4.3%) | 3 (40.5%) | 1.1b | 0.59 |
Gestation n (%) | ||||
Prematurity (<37 weeks) | 1 (4.3%) | 20 (27.0%) | ||
Term (≥37 weeks) | 21 (91.3%) | 47 (63.5%) | 5.9b | 0.02 |
Unavailable | 1 (4.3%) | 7 (9.5%) | ||
Small or large birth weight for gestational ageg n (%) | 6 (27.3%), M=1 | 10 (15.4%), M=9 | 1.6b | 0.22 |
Congenital malformations n (%) | 6 (26.1%) | 14 (18.9%) | 0.6b | 0.56 |
Birth process complicationsh n (%) | 14 (60.9%) | 46 (63%), M=1 | 0.03b | 0.52 |